The role of endothelial dysfunction in the pathogenesis of impaired diabetic wound healing: A novel therapeutic target?

Medical Hypotheses

Volumn 69, Issue 5, 2007, Pages 1029-1031

  Laing, T ^a   Hanson, R ^a   Chan, F ^a   Bouchier Hayes, D ^a  

^a BEAUMONT HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; NITRIC OXIDE SYNTHASE;

ARTICLE; ATHEROSCLEROSIS; CYTOKINE RELEASE; DIABETES MELLITUS; ENDOTHELIAL DYSFUNCTION; GLUCOSE BLOOD LEVEL; HUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; WOUND HEALING IMPAIRMENT;

ANTI-INFLAMMATORY AGENTS; DIABETIC ANGIOPATHIES; DRUG DELIVERY SYSTEMS; ENDOTHELIUM, VASCULAR; HUMANS; MODELS, BIOLOGICAL; WOUND HEALING;

EID: 34548729607     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2007.02.040     Document Type: Article

References (30)

1. Bloomgarden Z.T. American diabetes association 60th scientific sessions, 2000: the diabetic foot. Diabetes Care 24 5 (2001) 946-951
2. Greenhalgh D.G. Wound healing and diabetes mellitus. Clin Plast Surg 30 1 (2003) 37-45
3. Ahmed N. Advanced glycation endproducts - role in pathology of diabetic complications. Diabetes Res Clin Pract 67 1 (2005) 3-21
4. Blakytny R., and Jude E. The molecular biology of chronic wounds and delayed healing in diabetes. Diabetes Med 23 6 (2006) 594-608
5. Lobmann R., Ambrosch A., Schultz G., Waldmann K., Schiweck S., and Lehnert H. Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients. Diabetologia 45 7 (2002) 1011-1016
6. McMurry J.F. Wound healing with diabetes mellitus. Better glucose control for better wound healing in diabetes. J Surg Clin North Am 64 4 (1984) 769-778
7. Smiell J.M., Wieman T.J., Steed D.L., Perry B.H., Sampson A.R., and Schwab B.H. Efficacy and safety of becaplermin (recombinant human platelet-derived growth factor-BB) in patients with nonhealing, lower extremity diabetic ulcers: a combined analysis of four randomized studies. Wound Repair Regen 7 5 (1999) 335-346
8. Luo J.D., Wang Y.Y., Fu W.L., Wu J., and Chen A.F. Gene therapy of endothelial nitric oxide synthase and manganese superoxide dismutase restores delayed wound healing in type 1 diabetic mice. Circulation 110 16 (2004) 2484-2493
9. Varani J., Perone P., Merfert M.G., Moon S.E., Larkin D., and Stevens M.J. All-trans retinoic acid improves structure and function of diabetic rat skin in organ culture. Diabetes 51 12 (2002) 3510-3516
10. Kinlay S., Libby P., and Ganz P. Endothelial function and coronary artery disease. Curr Opin Lipidol 12 4 (2001) 383-389
11. Reduced endothelial nitric oxide synthase expression and production in human atherosclerosis. Circulation 1998;97(25):2494-8.
12. Paniagua O.A., Bryant M.B., and Panza J.A. Role of endothelial nitric oxide in shear stress-induced vasodilation of human microvasculature: diminished activity in hypertensive and hypercholesterolemic patients. Circulation 103 13 (2001) 1752-1758
13. Zhang W.Z., Venardos K., Chin-Dusting J., and Kaye D.M. Adverse effects of cigarette smoke on NO bioavailability: role of arginine metabolism and oxidative stress. Hypertension 48 2 (2006) 278-285
14. Cosentino F., and Luscher T.F. Endothelial dysfunction in diabetes mellitus. J Cardiovasc Pharmacol 32 Suppl. 3 (1998) S54-S61
15. Sjögren A., and Edvinsson L. Vasomotor changes in isolated coronary arteries from diabetic rats. Acta Physiol Scand 134 (1988) 429-436
16. Nitenberg A., Paycha F., Ledoux S., Sachs R., Attali J.R., and Valensi P. Coronary artery responses to physiological stimuli are improved by deferoxamine but not by l-arginine in non-insulin-dependent diabetic patients with angiographically normal coronary arteries and no other risk factors. Circulation 97 (1998) 736-743
17. Hogikyan R.V., Galecki A.T., Pitt B., Halter J.B., Greene D.A., and Supiano M.K. Specific impairment of endothelium-dependent vasodilation in subjects with type 2 diabetes. J Clin Endocrinol Metab 83 (1998) 1946-1952
18. Schaffer M.R., Tantry U., Effron P.A., Ahrendt G.M., Thornton F.J., and Barbul A. Diabetes-impaired healing and reduced wound nitric oxide synthesis: a possible pathophysiologic correlation. Surgery 121 5 (1997) 513-519
19. Stallmeyer B., Anhold M., Wetzler C., Kahlina K., Pfeilschifter J., and Frank S. Regulation of eNOS in normal and diabetes-impaired skin repair: implications for tissue regeneration. Nitric Oxide 6 2 (2002) 168-177
20. Witte M.B., Thornton F.J., Tantry U., and Barbul A. l-Arginine supplementation enhances diabetic wound healing: involvement of the nitric oxide synthase and arginase pathways. Metabolism 51 10 (2002) 1269-1273
21. Kampfer H., Pfeilschifter J., and Frank S. Expression and activity of arginase isoenzymes during normal and diabetes-impaired skin repair. J Invest Dermatol 121 6 (2003) 1544-1551
22. Witte M.B., Kiyama T., and Barbul A. Nitric oxide enhances experimental wound healing in diabetes. Brit J Surg 89 12 (2002) 1594-1601
23. Wetzler C., Kampfer H., Stallmeyer B., Pfeilschifter J., and Frank S. Large and sustained induction of chemokines during impaired wound healing in the genetically diabetic mouse: prolonged persistence of neutrophils and macrophages during the late phase of repair. J Invest Dermatol 115 2 (2000) 245-253
24. Kalani M., Brismar K., Fagrell B., Ostergren J., and Jorneskog G. Transcutaneous oxygen tension and toe blood pressure as predictors for outcome of diabetic foot ulcers. Diabetes Care 22 1 (1999) 147-151
25. Martin A., Komada M.R., and Sane D.C. Abnormal angiogenesis in diabetes mellitus. Med Res Rev 23 2 (2003) 117-145
26. Chowienczyk P.J., Brett S.E., Gopaul N.K., Meeking D., Marchetti M., Russell-Jones D.L., Anggard E.E., and Ritter J.M. Oral treatment with an antioxidant (raxofelast) reduces oxidative stress and improves endothelial function in men with type II diabetes. 977. Diabetologia 43 8 (2000) 974-977
27. Pieper G.M., and Siebeneich W. Diabetes-induced endothelial dysfunction is prevented by long-term treatment with the modified iron chelator, hydroxyethyl starch conjugated-deferoxamine. J Cardiovasc Pharmacol 30 6 (1997) 734-738
28. Butler R., Morris A.D., Belch J.J., Hill A., and Struthers A.D. Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension. Hypertension 35 3 (2000) 746-751
29. De las Heras N., Aragoncillo P., Maeso R., Vazquez-Perez S., Navarro-Cid J., DeGasparo M., et al. AT(1) receptor antagonism reduces endothelial dysfunction and intimal thickening in atherosclerotic rabbits. Hypertension 34 4 Pt 2 (1999) 969-975
30. Tousoulis D., Antoniades C., Koumallos N., Marinou K., Stefanadi E., Latsios G., et al. Novel therapies targeting vascular endothelium. Endothelium 13 6 (2006) 411-421